Day One Wednesday March 25, 2020 Day Two Thursday March 26, 2020 8:00 am Registration & Morning Coffee 8:50 am Chairperson Opening Remarks Establishing a Gold Standard for Bacteriophage Therapy Clinical Trials 9:00 am Moving Clinical Trials for Phage Therapy Forward: Maximizing the Likelihood for Informative and Significant Trials Shawna McCallin Clinical Researcher, Hopitaux Universitaires de Genève 9:30 am Phage Therapy Treatment of Acne and Other Chronic Diseases Sailaja Puttagunta CMO, BiomX 10:00 am Microbiology Support for Phage Therapy Trials: The Devils in the Details Daniel Stahm VP, Global Microbiology Services & CSO, International Health Management Associates 10:30 am Morning Refreshments & Networking 11:00 am Single-Molecule Long-Read Sequencing of Phage Mutational Landscape Tuval Ben-Yehezkel CEO, Loop Genomics Resisting Resistance: Ensuring Bacteriophage Is a Long-Term Viable Treatment Option 11:15 am Ensuring Phage is a Long-Term Viable Treatment Option Greg Merril Co-Founder & CEO , Adaptive Phage Therapeutics 11:45 am Development of Lysins for the Treatment of Multidrug Resistant Bacterial Infections Chandrabali Ghose CEO, Bioharmony Therapeutics 12:15 pm Engineering Phages to Widen Their Host Range To Overcome Bacterial Resistance Through Tail Fiber Mutagenesis Kevin Yehl Postdoctoral Research Associate, Massachusetts Institute of Technology 12:45 pm Lunch & Networking Where is Phage Therapy Heading? 2:00 pm Delivery of Therapeutic DNA Payloads via Phage-Derived Vectors Xavier Duportet Co-Founder & CEO , Eligo Bioscience 2:30 pm Bacterial Cybergenetics: Resurrecting Sensitivity to Antibiotics in Anti-Microbial Resistant Bacteria Conrad Lichtenstein CSO, Nemesis Bioscience 3:00 pm Delivery of Phage-Based Drugs, and Their Incorporation in Medical Devices Nancy Tawil VP, Human Health Research, Phagelux 3:30 pm Afternoon Refreshments & Networking Optimizing Phage Discovery and Treatment through Advances in Technology 4:00 pm Precision Biofilm Disruption and Vaginome Editing with Phage-Based Drug Candidates Lorenzo Corsini Co-Founder & CEO, PhagoMed 4:30 pm How Can Genome Sequencing Be Used to Identify Functionally Useful Bacteriophage Characteristics to Select Phages for Appropriate Production? Paul Turner Professor, Yale University 5:00 pm Chairperson Closing Remarks 5:10 pm Close of Conference Day Two